Obalon Therapeutics, Inc. (OBLN) Reaches $7.83 Low on Dec, 5; Last Week iRobot (IRBT) Analysts

December 5, 2017 - By Nellie Frank

Among 13 analysts covering IRobot Corporation (NASDAQ:IRBT), 4 have Buy rating, 2 Sell and 7 Hold. Therefore 31% are positive. IRobot Corporation had 25 analyst reports since September 18, 2015 according to SRatingsIntel. JP Morgan downgraded iRobot Corporation (NASDAQ:IRBT) on Friday, March 18 to “Underweight” rating. Dougherty & Company initiated iRobot Corporation (NASDAQ:IRBT) rating on Thursday, November 17. Dougherty & Company has “Buy” rating and $65 target. The firm has “Market Outperform” rating by JMP Securities given on Tuesday, October 13. The firm has “Hold” rating by Needham given on Monday, November 14. The rating was maintained by Canaccord Genuity with “Hold” on Wednesday, October 25. The firm has “Hold” rating by Dougherty given on Thursday, October 26. Raymond James downgraded the stock to “Market Perform” rating in Friday, September 18 report. As per Monday, October 17, the company rating was maintained by Benchmark. The firm has “Hold” rating given on Monday, December 4 by Citigroup. The stock of iRobot Corporation (NASDAQ:IRBT) has “Buy” rating given on Thursday, October 27 by Needham. See iRobot Corporation (NASDAQ:IRBT) latest ratings:

04/12/2017 Broker: Citigroup Rating: Hold New Target: $74.0 Initiate
27/10/2017 Broker: Sidoti Rating: Buy New Target: $90.0 Upgrade
26/10/2017 Broker: Dougherty Rating: Hold Maintain
26/10/2017 Broker: Needham Rating: Hold Maintain
25/10/2017 Broker: Canaccord Genuity Rating: Hold New Target: $65.0 Maintain
09/10/2017 Broker: Needham Rating: Hold
13/09/2017 Broker: J.P. Morgan Rating: Sell
09/08/2017 Broker: Canaccord Genuity Rating: Hold New Target: $95.0000 Maintain
26/07/2017 Broker: Piper Jaffray Rating: Hold New Target: $92.0000
03/07/2017 Broker: Dougherty Rating: Hold Downgrade

The stock of Obalon Therapeutics, Inc. (NASDAQ:OBLN) reached all time low today, Dec, 5 and still has $7.60 target or 3.00% below today’s $7.83 share price. This indicates more downside for the $136.57 million company. This technical setup was reported by Barchart.com. If the $7.60 PT is reached, the company will be worth $4.10M less. The stock decreased 1.01% or $0.08 during the last trading session, reaching $7.83. About 13,969 shares traded. Obalon Therapeutics, Inc. (NASDAQ:OBLN) has 0.00% since December 5, 2016 and is . It has underperformed by 16.70% the S&P500.

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The company has market cap of $136.57 million. It offers the Obalon balloon system designed to provide weight loss in obese patients. It currently has negative earnings.

Among 2 analysts covering Obalon Therapeutics (NASDAQ:OBLN), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Obalon Therapeutics has $21 highest and $18 lowest target. $19.50’s average target is 149.04% above currents $7.83 stock price. Obalon Therapeutics had 2 analyst reports since October 31, 2016 according to SRatingsIntel. The stock of Obalon Therapeutics, Inc. (NASDAQ:OBLN) earned “Buy” rating by UBS on Monday, October 31. The firm earned “Buy” rating on Monday, October 31 by Stifel Nicolaus.

Analysts await Obalon Therapeutics, Inc. (NASDAQ:OBLN) to report earnings on February, 22. They expect $-0.48 earnings per share, up 5.88% or $0.03 from last year’s $-0.51 per share. After $-0.55 actual earnings per share reported by Obalon Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -12.73% EPS growth.

The stock increased 1.46% or $0.94 during the last trading session, reaching $65.53. About 622,232 shares traded. iRobot Corporation (NASDAQ:IRBT) has risen 150.93% since December 5, 2016 and is uptrending. It has outperformed by 134.23% the S&P500.

iRobot Corporation designs, builds, and sells robots for the consumer market worldwide. The company has market cap of $1.83 billion. It offers Roomba floor vacuuming robots; Braava family of automatic floor mopping robots; Mirra Pool Cleaning Robot to clean residential pools and removes debris as small as two microns from pool floors, walls, and stair; and Looj Gutter Cleaning Robot. It has a 32.14 P/E ratio.

Investors sentiment decreased to 1.05 in 2017 Q2. Its down 0.30, from 1.35 in 2017Q1. It turned negative, as 36 investors sold iRobot Corporation shares while 70 reduced holdings. 44 funds opened positions while 67 raised stakes. 22.32 million shares or 5.25% less from 23.55 million shares in 2017Q1 were reported. Parallax Volatility Advisers Limited Partnership owns 9,731 shares or 0% of their US portfolio. Anderson Hoagland has invested 0.95% in iRobot Corporation (NASDAQ:IRBT). Paradigm Asset Lc stated it has 400 shares. Baillie Gifford & accumulated 746,771 shares. Tci Wealth Advisors reported 9 shares stake. Washington-based Fisher Asset Mgmt Ltd Limited Liability Company has invested 0% in iRobot Corporation (NASDAQ:IRBT). Proshare Advsrs Lc stated it has 0% of its portfolio in iRobot Corporation (NASDAQ:IRBT). Thompson Davis holds 250 shares or 0.03% of its portfolio. Pictet Asset Mngmt Ltd holds 0.15% in iRobot Corporation (NASDAQ:IRBT) or 523,697 shares. Gotham Asset Mgmt Ltd reported 17,852 shares stake. Teachers Retirement Systems Of The State Of Kentucky holds 9,700 shares. 4,706 were reported by Shelton Capital. Deutsche Fincl Bank Ag reported 335,939 shares. 4,372 are held by Royal Bank Of Canada. Moreover, Hartford Fincl Mngmt has 0% invested in iRobot Corporation (NASDAQ:IRBT) for 125 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com